Karyopharm Therapeutics Inc. (KPTI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Karyopharm Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.41x | -1.08x | -0.69x | -1.68x | -3.89x | -5.67x |
| P/B Ratio | -0.27x | -0.44x | -0.73x | -16.71x | -6.06x | 22.04x |
| P/S Ratio | 0.55x | 0.57x | 0.68x | 1.77x | 2.30x | 10.30x |
| Profitability | ||||||
| Gross Margin | 95.9% | 95.9% | 96.6% | 96.7% | 98.4% | 97.5% |
| Operating Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% |
| Net Margin | -134.2% | -52.6% | -98.0% | -105.2% | -59.1% | -181.6% |
| EBITDA Margin | -102.6% | -26.6% | -81.1% | -88.7% | -46.2% | -155.3% |
| Liquidity | ||||||
| Current Ratio | 1.12x | 1.70x | 3.37x | 5.31x | 3.74x | 4.59x |
| Quick Ratio | 1.08x | 1.64x | 3.32x | 5.25x | 3.68x | 4.55x |
| Leverage | ||||||
| Debt/Equity | -0.80x | -1.05x | -1.30x | -10.75x | -2.27x | 2.59x |
YoY = year-over-year change. Source: FMP..